BackFulcrum Therapeutics Overview
Fulcrum Therapeutics Inc

Fulcrum Therapeutics Target Price

Analysts' 12-month price predictions for FULC.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.85

Average Target Price

$5.8351.5% upside

6 analysts in the last 4 months

High: $17 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-02H.C. WainwrightAndrew Fein$322.1% downsideOpen
2026-06-02Jefferies$43.9% upsideOpen
2026-06-02Leerink Partners$43.9% upsideOpen
2026-06-02Truist FinancialGregory Renza$43.9% upsideOpen
2026-06-02Piper Sandler$322.1% downsideOpen
2026-02-24Truist FinancialGregory Renza$17341.6% upsideOpen
2025-12-11Truist Financial$18367.5% upsideOpen
2025-12-08Stifel Nicolaus$25549.4% upsideOpen
2025-12-08Cantor FitzgeraldKristen Kluska$24523.4% upsideOpen
2025-12-08RBC Capital$10159.7% upsideOpen
2025-12-08Piper Sandler$23497.4% upsideOpen
2025-12-08H.C. Wainwright$25549.4% upsideOpen
2025-11-24Truist Financial$14263.6% upsideOpen
2025-11-24H.C. WainwrightAndrew Fein$18367.5% upsideOpen
2025-10-30Piper Sandler$16315.6% upsideOpen
2025-10-21Leerink Partners$20419.5% upsideOpen
2025-07-29H.C. Wainwright$12211.7% upsideOpen
2025-05-29Piper SandlerEdward Tenthoff$9133.8% upsideOpen
2025-05-23Leerink PartnersJoseph Schwartz$12211.7% upsideOpen
2024-09-13H.C. WainwrightAndrew Fein$43.9% upsideOpen
2024-09-12RBC CapitalGregory Renza$43.9% upsideOpen
2024-09-12Stifel NicolausDae Gon Ha downgraded Fulcrum Therapeutics$322.1% downsideOpen
2024-09-12Bank of America SecuritiesTazeen Ahmad$248.1% downsideOpen
2024-09-09Bank of America SecuritiesTazeen Ahmad$10159.7% upsideOpen
2024-09-03RBC CapitalGregory Renza$15289.6% upsideOpen
2024-05-20Cantor FitzgeraldKristen Kluska$23497.4% upsideOpen
2024-05-13Goldman SachsCorinne Jenkins$15289.6% upsideOpen
2024-05-13Stifel NicolausDae Gon Ha$22471.4% upsideOpen
2024-03-13RBC CapitalGregory Renza$14263.6% upsideOpen
2022-11-15Goldman Sachs$11185.7% upsideOpen
2022-11-08Piper SandlerEdward Tenthoff$18367.5% upsideOpen